Connection

Katie Doores to Immunogenicity, Vaccine

Back to Details
This is a "connection" page, showing publications Katie Doores has written about Immunogenicity, Vaccine.
Katie Doores
Connection Strength
0.018
Immunogenicity, Vaccine
  1. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol. 2021 06; 22(6):765-778.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.